Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Common Shares	Additional Paid-in- Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Common Shares in Treasury, at cost
Beginning Balance at Oct. 31, 2022	$ 2,294,375	$ 12,253	$ 626,697	$ 3,652,216	$ (207,782)	$ (1,789,009)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under company stock and employee benefit plans	21,373		17,858			3,515
Stock-based compensation	23,542		23,542
Purchase of treasury shares, value	(89,708)					(89,708)
Dividends declared	(150,356)			(150,356)
Net income	487,493			487,493
Other comprehensive income (loss):	11,341				11,341
Other Comprehensive Income (Loss):
Foreign currency translation and related hedging instruments	26,766
Ending Balance at Oct. 31, 2023	2,598,060	12,253	668,097	3,989,353	(196,441)	(1,875,202)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under company stock and employee benefit plans	31,067		27,037			4,030
Stock-based compensation	18,957		18,957
Purchase of treasury shares, value	(33,339)					(33,339)
Dividends declared	(161,438)			(161,438)
Net income	467,284			467,284
Other comprehensive income (loss):	11,601				11,601
Other Comprehensive Income (Loss):
Foreign currency translation and related hedging instruments	16,390
Ending Balance at Oct. 31, 2024	2,932,192	12,253	714,091	4,295,199	(184,840)	(1,904,511)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued under company stock and employee benefit plans	9,014		7,754			1,260
Stock-based compensation	18,944		18,944
Purchase of treasury shares, value	(306,367)					(306,367)
Dividends declared	(179,069)			(179,069)
Net income	484,474			484,474
Other comprehensive income (loss):	84,383				84,383
Other Comprehensive Income (Loss):
Foreign currency translation and related hedging instruments	66,372
Ending Balance at Oct. 31, 2025	$ 3,043,571	$ 12,253	$ 740,789	$ 4,600,604	$ (100,457)	$ (2,209,618)